Font Size: a A A
Keyword [Convertase]
Result: 21 - 40 | Page: 2 of 3
21. The Effects Of Ticagrelor On PCSK9, Inflammation Factor Expression And Their Relations In Apoptosis Of Human Umbilical Vein Endothelial Cells Induced By Ox-LDL
22. Effect Of Different Statins Therapy On The Expression Of Proprotein Convertase Subtilisin/kexin 9 In Human Attacked By Acute ST Elevation Myocardial Infarction
23. The Change Of Serum PCSK9 Level In Patients With Coronary Heart Disease And Correlation Analysis With LPS
24. Effects Of Difluoromethyl Oleanolate On Lipid Uptake And Accumulation Via PCSK9 In HepG2 Cells
25. Discovery Of Natural Products With Lipid-lowering Activity And Their Mechanism Of Action
26. The Study Of A Therapeutic Peptide Vaccine Against PCSK9
27. The Study On The Expression And Mechanism Of Apoptosis Regulatory Factors(miR-322,PCSK9) In Animal Model Of Neural Tube Defect
28. Study On The Mechanism Of C1q/Tumor Necrosis Factor-related Protein-3 Regulating LDLR Expression Through AKT Signaling Pathway In HepG2 Cells
29. Expression And Significance Of PCSK9 And LOX-1 In Hippocampus Of T2DM Rats
30. Investigating The Relationship Between PCSK9 And Atherosclerosis Risk Factors For T2DM
31. PCSK9 Overexpression Was A Risk Factor In The Biological Behavior Of Gastric Cancer
32. Progress In Research Of PCSK9 Inhibitors In The Treatment Of Cardiovascular Diseases
33. Short-term Risk Asessment Of Serum PCSK9 And Lp(a) In Young And Middle-aged Patients With Acute ST Segmental Elevation Myocardial Infarction
34. MircoRNA-224 Inhibits Vascular Smooth Muscle Cell Lipid Accumulation Via PCSK9/LOX-1 Pathway
35. Correlation Between PCSK9 Level And Severity Of Coronary Artery Stenosis In Acute Coronary Syndrome
36. Correlation Between Serum PCKS9,Lp(a),FIb Levels And The Severity Of Coronary Lesions In Patients With Acute Coronary Syndrome
37. A New Mechanism For Negative Feedback Regulation Of LDL/LDLR:The Lipophagy Mediated PCSK9-LDLR Degradation Pathway
38. The Mechanism Of PCSK9 By Curcumin Regulating Uptake Of Plasma LDL-C By Hepatocytes
39. Expression And Clinical Significance Of Proprotein Convertase Subtilisin/Kexin Type 9 In Patients With Type 2 Diabetic Kidney Disease
40. Impact Of Lowering Low-Density Lipoprotein Cholesterol With Contemporary Lipid-Lowering Medicine On Cognitive Function
  <<First  <Prev  Next>  Last>>  Jump to